Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients

Clinical trial NCT01359969 · COMPLETED

Trial details

NCT number: NCT01359969
Sponsor: Pharming Technologies B.V.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hereditary Angioedema

Start date: 2012-01-17
Primary completion: 2017-07-17
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.